Today: 21 May 2026

Coinbase stock ticks up after-hours as Cantor cuts target; earnings and bitcoin in focus this week

Coinbase stock ticks up after-hours as Cantor cuts target; earnings and bitcoin in focus this week

Coinbase Global shares rose about 1.3% to $167.25 in late after-hours trading Monday, tracking steady bitcoin prices near $70,267. Cantor Fitzgerald cut its price target on Coinbase to $221 from $277 but kept an overweight rating. Coinbase reports quarterly results Thursday after the close. The stock traded between $159.36 and $168.00 during the session.
Spotify stock price dips after hours as SPOT earnings near — what investors watch Tuesday

Spotify stock price dips after hours as SPOT earnings near — what investors watch Tuesday

Spotify shares fell 1.8% to $414.84 in after-hours trading Monday ahead of its quarterly earnings report due Tuesday morning. Investors are watching for updates on subscriber growth, churn, and margins after recent price hikes. Spotify reported more than 713 million users and 281 million subscribers globally. The company raised its U.S. premium price to $12.99 last month.
CyberArk stock rises as Nasdaq flags Feb. 11 close for Palo Alto takeover

CyberArk stock rises as Nasdaq flags Feb. 11 close for Palo Alto takeover

CyberArk shares rose 4.4% to $409.22 after Nasdaq said its merger with Palo Alto Networks is expected to close before the market opens Feb. 11. Nasdaq plans to halt CyberArk trading after Tuesday’s after-hours session, with suspension effective Feb. 12 if the deal closes. The offer values CyberArk at about $410 per share based on Palo Alto’s latest price.
Tesco grabs Amazon Fresh’s abandoned London stores as it rolls out 70+ new Express shops

Tesco grabs Amazon Fresh’s abandoned London stores as it rolls out 70+ new Express shops

Tesco has acquired five former Amazon Fresh sites in London and will reopen them as Tesco Express stores before summer. The company plans over 70 more Express openings by March 2027, after adding 60 last year. The acquired locations include Kensington High Street, Hounslow, Moorgate, Aldgate East, and Wembley. Tesco shares were little changed in London trading.
10 February 2026
CoreWeave stock price jumps nearly 8% as CRWV rebounds; lawsuits and Feb. 26 earnings in focus

CoreWeave stock price jumps nearly 8% as CRWV rebounds; lawsuits and Feb. 26 earnings in focus

CoreWeave shares closed up 7.6% at $96.79 Monday, swinging between $87.39 and $97.86, and held steady after hours. The move followed a tech-led rally in U.S. stocks ahead of key payrolls and inflation data. Plaintiff law firms issued new notices about a securities class action, with a lead-plaintiff deadline set for March 13. CoreWeave will report earnings on Feb. 26.
Hims & Hers stock sinks after $49 Wegovy copycat U-turn and Novo Nordisk lawsuit

Hims & Hers stock sinks after $49 Wegovy copycat U-turn and Novo Nordisk lawsuit

Hims & Hers Health shares plunged 16% in after-hours trading Monday after the company pulled its $49 compounded semaglutide pill amid a patent lawsuit from Novo Nordisk. The stock touched $16.44 before recovering some losses. Novo seeks a court order to stop sales of unapproved compounded drugs. Leerink Partners cut its price target on Hims, citing uncertainty over future sales of compounded semaglutide.
Robinhood stock jumps after Wolfe upgrade as HOOD heads into earnings

Robinhood stock jumps after Wolfe upgrade as HOOD heads into earnings

Robinhood shares climbed 4.5% to $86.56 in after-hours trading Monday after Wolfe Research upgraded the stock and set a $125 price target. The move comes ahead of Robinhood’s fourth-quarter earnings release Tuesday, with investors watching for trends in trading and crypto revenue. Barclays warned that weak crypto sentiment and regulatory risks could weigh on results. Robinhood will hold its earnings call at 5 p.m. ET.
Palo Alto Networks (PANW) stock jumps as CyberArk merger close nears; traders eye Feb. 17 results

Palo Alto Networks (PANW) stock jumps as CyberArk merger close nears; traders eye Feb. 17 results

Palo Alto Networks shares rose 4.2% to $166 Monday, steady after hours, as Nasdaq said its $25 billion CyberArk merger is tentatively set to close before the Feb. 11 open. CyberArk shares are expected to be halted after trading Tuesday. Barclays cut its Palo Alto price target but kept an overweight rating. Morgan Stanley called Palo Alto its “favorite” cybersecurity stock for AI exposure.

Stock Market Today

  • Stock Market Today: Key Insights for May 21 Trading
    May 20, 2026, 10:27 PM EDT. Stocks in the news and major brokerage calls shape market sentiment as traders prepare for May 21. This report provides a complete trade setup, highlighting critical market movements and strategies. Stay informed with the essential data before entering trades today.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop